Macular Degeneration: The Complete Guide

Macular Degeneration: The Complete Guide

by LS&S

$16.95

Ready to use This is a printed book requiring no setup, pairing, or professional guidance — buy it, open it, read it. Self-serve is clearly appropriate.

Last verified June 18, 2026 · classified April 26, 2026

What it is

Summary

AI-generated from vendor-published content · April 26, 2026

This is a consumer book by ophthalmologist Lylas Mogk, MD, covering age-related macular degeneration (AMD) — a condition causing central vision loss common in older adults. It explains the medical basics in plain language and then shifts to practical strategies for daily life with low vision, making it useful for someone newly diagnosed or a family member trying to understand what's ahead. You're getting a standalone printed resource, not a device or service — it can complement professional care but doesn't replace it. Readers with significant vision loss may find the standard print format ironic given the subject matter, so pairing it with a magnifier or requesting a large-print edition is worth considering.

Quick Facts Catalog facts · auto-generated
Age range
ComplexityReady to use
Price$16.95
Funding
  • Out of pocket
VerifiedJune 18, 2026
ClassifiedApril 26, 2026 · confidence: high
VendorLS&S ↗

What Setup Looks Like

  • Out of the box
    Open and read — no setup required.

Getting it

Many states lend devices like this for free trial periods — find your state's AT lending program.

Where to Get It

lss-products Visit
$16.95

Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →

As an Amazon Associate we earn from qualifying purchases.

Wondering how equipment like this gets paid for? See the official funding programs in your state.

Sources & fine print

Vendor facts (name, price, platforms, vendor link) sourced from LS&Sview on vendor site; last verified June 18, 2026.

Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.